Libivirumab

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Libivirumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
TargetHepatitis B surface antigen
Clinical data
ATC code
  • none
Identifiers
CAS Number
  • 569658-79-3 ☒N
ChemSpider
  • none
UNII
Chemical and physical data
FormulaC6598H10232N1788O2060S46
Molar mass149039.65 g·mol−1
 ☒NcheckY (what is this?)  (verify)

Libivirumab is a human monoclonal antibody directed against the hepatitis B virus.[1][2]

References[edit]

  1. ^ WHO Drug Information
  2. ^ Shouval D, Terrault N, Galun E, Samuel D, Gane E, Pruett T, et al. (2006). "Anti-Viral Effects, Pharmacokinetics and Safety of Two Human Monoclonal Anti-Hbs (Libivirumab/Exbivirumab) Versus Hepatitis B Immune Globulin (Hbig) in Hepatitis B Virus (Hbv) in Liver Transplant (Lt) Recipients". Hepatology. 44 (4): 188A–700A [196A]. doi:10.1002/hep.21395.